pharma · Hypertension · Uncontrolled and Resistant Hypertension · MLYS
Mineralys Therapeutics
Mineralys Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Radnor, USA HQ
2020 Founded
106 Employees
Public company Type
MLYS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Radnor, USA
- Founded
- 2020
- Employees
- 106
- Programs
- 7
- Drugs
- 6
- Patents
- 0
Mineralys Therapeutics projects
3 ClinicalTrials.gov programs sponsored by Mineralys Therapeutics.
Mineralys Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Mineralys Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.